Blue Jet Healthcare Ltd

Blue Jet Healthcare Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, moving from fair to expensive territory. Despite a modest day gain of 0.97%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now signal a more cautious outlook for investors amid broader market headwinds and sector dynamics.

Blue Jet Healthcare Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a notable gap up of 9.95%, reflecting a positive market sentiment despite recent downward trends. The stock’s intraday high reached Rs 446.9, marking a significant recovery after three consecutive days of decline.

Blue Jet Healthcare Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has recently undergone a notable shift in its valuation parameters. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have moderated from previously expensive levels to a fair valuation band, signalling a potential recalibration of investor sentiment. However, despite this improvement, the stock continues to face headwinds amid broader market underperformance and sectoral pressures.

Blue Jet Healthcare Ltd’s stock declined to a fresh 52-week low of Rs.402.65 on 2 Feb 2026, marking a continuation of its downward trajectory over recent sessions despite a broadly positive market backdrop.

Blue Jet Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.409.05 on 1 Feb 2026, marking a significant drop amid broader market volatility and company-specific performance factors.

Blue Jet Healthcare Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.411.35 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.

Blue Jet Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 January 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and market performance.

Blue Jet Healthcare Ltd’s stock declined to a fresh 52-week low of Rs.414 today, marking a significant milestone in its recent price trajectory. The stock has been under pressure for the past three sessions, cumulatively losing 8.67% over this period, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector.

Blue Jet Healthcare Ltd’s stock declined to a fresh 52-week low of Rs.422.05 on 27 Jan 2026, marking a significant downturn amid broader sectoral pressures and subdued financial metrics. The stock has now recorded a consecutive two-day fall, accumulating a loss of 6.13% over this period.

Blue Jet Healthcare Ltd’s stock declined sharply to a new 52-week low of Rs.439.5 on 23 Jan 2026, marking a significant downturn in its share price amid broader sector and market pressures.

Blue Jet Healthcare Ltd’s stock touched a fresh 52-week low of Rs.470.85 today, marking a significant decline amid a broader market downturn. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of recent financial and market developments.

Blue Jet Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.472.2 on 19 Jan 2026, marking a significant price level amid a challenging market environment and subdued financial performance over the past year.

Blue Jet Healthcare Ltd’s stock touched a fresh 52-week low of Rs.490 on 14 Jan 2026, marking a significant decline amid a series of underwhelming financial indicators and market pressures. The stock has been on a downward trajectory over the past two days, reflecting broader concerns within the Pharmaceuticals & Biotechnology sector.

Blue Jet Healthcare Ltd’s stock touched a fresh 52-week low of Rs.490.4 today, marking a significant decline amid a year of underwhelming returns and subdued financial metrics. The pharmaceutical and biotechnology company’s shares have been trading below all major moving averages, reflecting persistent downward pressure despite a modest rebound after two consecutive days of losses.

Blue Jet Healthcare Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has declined to a fresh 52-week low of Rs.497.75, marking a significant price level for the stock amid subdued market conditions and company-specific performance factors.

Blue Jet Healthcare Ltd’s stock declined sharply to a fresh 52-week low of Rs.512 on 8 Jan 2026, marking a significant retreat from its previous levels amid broader market weakness and company-specific performance factors.

Blue Jet Healthcare Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 6 January 2026, reflecting a combination of deteriorating technical indicators, flat financial performance, and valuation concerns despite strong long-term fundamentals. The downgrade highlights growing investor caution amid mixed signals across quality, valuation, financial trends, and technical parameters.